EquitAI LogoEquitAI
$87.90
-2.02%
DXCM

DXCM

DexCom, Inc.

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
5/10
Quality
10/10
Growth
7/10
Strength
7/10
Dividend
1/10
Price Trend
Upwards
Momentum
Neutral
Balance Sheet
Healthy
Earnings
Growth
Dividend Yield
0.00%
Market Cap
$33.17B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

DexCom designs and manufactures continuous glucose monitoring systems for diabetes management. The company provides wearable sensors that track blood sugar levels in real-time, largely replacing traditional fingerstick testing. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...